May. 18 CS Medica A/S Revises Revenue Guidance for the Year 2025-2026 CI
Apr. 01 CS Medica A/S Elects Jens Hagelskjær as Board Director CI
Jan. 21 CS Medica A/S Reports Earnings Results for the First Quarter Ended December 31, 2025 CI
Nov. 30 CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2025 CI
Nov. 30 CS Medica A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2025 CI
Nov. 30 CS Medica A/S Provides Revenue Guidance for the Fourth Quarter of 2025 CI
25-05-17 CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 CI
25-04-16 CS Medica A/S Approves Board Changes CI
25-03-31 CS Medica A/S Announces Co-CEO Changes CI
25-03-31 CS Medica A/S Reports Earnings Results for the First Quarter Ended December 31, 2024 CI
25-02-17 CS Medica A/S Announces Board Changes CI
25-02-17 CS Medica A/S Announces CEO Changes CI
25-01-10 CS MEDICA Achieves Fourth European Patent with Psoriasis Gel AQ
25-01-09 Ahead of delisting: CS Medica temporarily suspends all non-revenue generating activities FW
25-01-09 CS MEDICA: CEO Letter: A Moment of Transition for CS MEDICA PU
25-01-09 CEO Letter: A Moment of Transition for CS MEDICA AQ
25-01-09 CS Medica has today the last trading day on Spotlight before delisting FW
25-01-07 CS Medica has signed white label partnership for launch in Italy FW
25-01-06 CS Medica Unit Secures Partnership Deal in Italy MT
25-01-02 CS Medica aims for OTC trading after delisting FW
25-01-01 Update from Chairperson: Delisting of CS MEDICA A/S from Spotlight Stock Market AQ
24-12-27 After the delisting announcement: CS Medica in discussions with new trading platforms FW
24-12-23 CS MEDICA Explores Listing and Strategic Options to Protect Shareholder & Company Value AQ
24-12-20 CS Medica will actively explore listing options - hopes to resolve situation with Spotlight FW
24-12-19 CS MEDICA: CS MEDICA Responds to Spotlight Stock Market’s Delisting Notification PU
No results for this search